260 related articles for article (PubMed ID: 20638238)
1. A novel mechanism of thrombosis in antiphospholipid antibody syndrome.
Vlachoyiannopoulos PG; Routsias JG
J Autoimmun; 2010 Nov; 35(3):248-55. PubMed ID: 20638238
[TBL] [Abstract][Full Text] [Related]
2. {beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome.
Sikara MP; Routsias JG; Samiotaki M; Panayotou G; Moutsopoulos HM; Vlachoyiannopoulos PG
Blood; 2010 Jan; 115(3):713-23. PubMed ID: 19805618
[TBL] [Abstract][Full Text] [Related]
3. Anti-beta2-glycoprotein I antibodies recognizing platelet factor 4-heparin complex in antiphospholipid syndrome in patient substantiated with mouse model.
Bourhim M; Darnige L; Legallais C; Arvieux J; Cevallos R; Pouplard C; Vijayalakshmi MA
J Mol Recognit; 2003; 16(3):125-30. PubMed ID: 12833567
[TBL] [Abstract][Full Text] [Related]
4. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V.
Shi T; Giannakopoulos B; Yan X; Yu P; Berndt MC; Andrews RK; Rivera J; Iverson GM; Cockerill KA; Linnik MD; Krilis SA
Arthritis Rheum; 2006 Aug; 54(8):2558-67. PubMed ID: 16868978
[TBL] [Abstract][Full Text] [Related]
5. The role of thrombospondin-1 in the pathogenesis of antiphospholipid syndrome.
Patsouras M; Tsiki E; Karagianni P; Vlachoyiannopoulos PG
J Autoimmun; 2020 Dec; 115():102527. PubMed ID: 32709480
[TBL] [Abstract][Full Text] [Related]
6. The role of beta 2-glycoprotein I-dependent lupus anticoagulants in the pathogenesis of the antiphospholipid syndrome.
Arnout J
Verh K Acad Geneeskd Belg; 2000; 62(5):353-72. PubMed ID: 11144685
[TBL] [Abstract][Full Text] [Related]
7. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
[TBL] [Abstract][Full Text] [Related]
8. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
9. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
10. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
Sheng Y; Kandiah DA; Krilis SA
J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of platelet-derived chemokines in patients with antiphospholipid syndrome.
Patsouras MD; Sikara MP; Grika EP; Moutsopoulos HM; Tzioufas AG; Vlachoyiannopoulos PG
J Autoimmun; 2015 Dec; 65():30-7. PubMed ID: 26283469
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of chemokine-induced platelet activation in thrombophilic diathesis of antiphospholipid syndrome.
Kubota T; Fukuya Y; Hashimoto R; Kanda T; Suzuki H; Okamura Y; Nanki T; Miyasaka N; Umezawa K
Ann N Y Acad Sci; 2009 Sep; 1173():137-45. PubMed ID: 19758142
[TBL] [Abstract][Full Text] [Related]
13. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
Adams M
Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of a non-phospholipid-binding form of beta2-glycoprotein I in human plasma--consequences for the development of anti-beta2-glycoprotein I antibodies.
Horbach DA; van Oort E; Tempelman MJ; Derksen RH; de Groot PG
Thromb Haemost; 1998 Nov; 80(5):791-7. PubMed ID: 9843173
[TBL] [Abstract][Full Text] [Related]
15. Anti-β2 glycoprotein I antibodies in complex with β2 glycoprotein I induce platelet activation via two receptors: apolipoprotein E receptor 2' and glycoprotein I bα.
Zhang W; Gao F; Lu D; Sun N; Yin X; Jin M; Liu Y
Front Med; 2016 Mar; 10(1):76-84. PubMed ID: 26620053
[TBL] [Abstract][Full Text] [Related]
16. β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome.
Tanimura K; Jin H; Suenaga T; Morikami S; Arase N; Kishida K; Hirayasu K; Kohyama M; Ebina Y; Yasuda S; Horita T; Takasugi K; Ohmura K; Yamamoto K; Katayama I; Sasazuki T; Lanier LL; Atsumi T; Yamada H; Arase H
Blood; 2015 Apr; 125(18):2835-44. PubMed ID: 25733579
[TBL] [Abstract][Full Text] [Related]
17. In vitro effect of anti-β₂ glycoprotein I antibodies on P-selectin expression, a marker of platelet activation.
Bontadi A; Ruffatti A; Giannini S; Falcinelli E; Tonello M; Hoxha A; Gresele P; Punzi L
Reumatismo; 2012 Mar; 64(1):35-9. PubMed ID: 22472781
[TBL] [Abstract][Full Text] [Related]
18. The immunology of atherothrombosis in the antiphospholipid syndrome: antigen presentation and lipid intracellular accumulation.
Matsuura E; Kobayashi K; Matsunami Y; Lopez LR
Autoimmun Rev; 2009 May; 8(6):500-5. PubMed ID: 19171205
[TBL] [Abstract][Full Text] [Related]
19. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
20. Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis.
Yasuda S; Atsumi T; Ieko M; Koike T
Thromb Res; 2004; 114(5-6):461-5. PubMed ID: 15507279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
